FDA Investigator Kula N Jha
Kula N Jha has conducted inspections on 3 sites in 2 countries as of 17 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
17 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Switzerland
FDA Investigators that have inspected at least one site in common with Kula N Jha:
Ademola O Daramola,
Andrew W Harmon,
Angel K Sandhu,
Anh M Lac,
Anjali Shukla, PhD,
Ashar P Parikh,
Barbara M Frazier,
Bradley Dworak, PhD,
Bruce H Mccullough,
Candace Y Gomez Broughton,
Carl Lee,
Carolyn A Renshaw,
CDR Donald Ertel,
CDR Rochelle B Young, RPh, MSA,
Charles I Ann,
Christian D Lynch (CDL),
Cynthia J Lee, MS,
Cynthia Jim, CSO,
Cynthia M Goudeau,
Daniel C Kearns,
David M Beltran,
Devaughn Edwards,
Don H Bark, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin P Tran,
Edmund F Mrak, Jr,
Eileen A Liu,
Emmanuel Adu Gyamfi, PhD,
Gene D Arcy,
Gwyn G Dickinson,
Helen B Ricalde,
Henry K Lau,
Hung H Do, MS,
Jacqueline Mdiaz Albertini,
James R Evans,
Jeffrey D Meng,
Jeffrey M Watson,
Jessica Chery,
Jolanna A Norton,
Joslyn K Brunelle, PhD,
Julie D Bringger,
Kalavati Suvarna, PhD,
Kathleen R Jones, PhD,
Kent C Faul,
Kevin D Kallander,
Kevin P Foley,
Kham Phommachanh,
Kim Lthomas Cruse,
Lance Mde Souza, MBA,
Laura Fontan, MS,
Laurel A Beer,
LCDR Debra Emerson,
Linda M Cheny,
Mariza M Jafary,
Mei Chiung Huang (Jo),
Michele L Forster, PhD,
Michele L Obert,
Mihaly S Ligmond,
Paula A Trost,
Prabhu P Raju,
Ralph A Erickson,
Randy L Self,
Raymond T Oji,
Rebecca Rodriguez,
Regina T Brown,
Richard Heath Coats,
Robert C Coleman,
Robert Jennings,
Rose Ashley,
Seneca D Toms,
Shawn R Gould,
Sherri J Jackson,
Sidney B Priesmeyer,
Susan M Jackson,
Thomas A Peter,
Thomas J Arista,
Thomas R Withers,
Travis S Bradley,
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Vlada Matusovsky,
Wayne E Seifert,
Wei Wang, PhD,
William V Millar,
Xiaokuang Lai, PhD,
Ying Xin Fan, PhD,
Yiyue Zhang (nmi), PhD,
Yonggang Wang, PhD,
Zhong Li, PhD
Kula N Jha's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2022 | FDA 483 | BioMarin Pharmaceutical Inc. - Form 483, 2022-12-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more